Share Capital - Schedule of Share Based Compensation, Stock Appreciation Rights (Details) - Stock Appreciation Rights (SARs) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2021
Shares
Beginning balance (in shares)	4,845,000
Granted (in shares)	225,000
Exercised (in shares)	(1,948,000)
Ending balance (in shares)	3,122,000
Weighted Average Grant Date Fair Value
Weighted average grant date fair value, beginning balance (in dollars per share)	$ 2.78
Weighted average grant date fair value, granted (in dollars per share)	2.23	$ 2.39
Weighted average grant date fair value, exercised (in dollars per share)	3.02
Weighted average grant date fair value, ending balance (in dollars per share)	2.59
Weighted Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share)	4.57
Weighted average exercise price, granted (in dollars per share)	6.79
Weighted average exercise price, exercised (in dollars per share)	$ 2.93
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	2,400,000